Myriad Genetics, Inc. Financial Ratios — MYGN Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	17.91	18.65	21.58	24.34	11.61	16.62	2.29	15.37	0.45	-19.88	-2.88	-12.08	-31.55	-17.15	-68.45
Return on Assets (%)	16.72	17.23	19.7	21.65	10.09	14.23	1.67	11.18	0.34	-13.45	-2	-8.89	-22.45	-11.71	-42.2
Return on Capital (%)	17.91	18.65	21.58	24.34	11.63	16.65	2.53	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	17.83	18.35	21.28	24.22	11.61	16.44	2.55	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	88.38	86.96	87	85.97	79.62	78.76	76.51	76.17	76.38	70.86	71.39	70.22	68.64	69.89	69.93
EBITDA Margin (%)	41.04	38.18	38.63	37.03	22.02	24.33	12.56	15.48	9.47	-9.4	-9.25	-10.47	-10.98	-3.2	-1.71
Operating Margin (%)	39.24	36.35	37.18	35.26	18.56	20.72	5.93	8.16	0.89	-20.67	-18.35	-18.23	-19.2	-10.51	-8.22
Incremental Operating Margin (%)	57.57	24	40.69	28.12	254.45	110.34	933.9	116.67	-49.44	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	39.71	37.21	38.05	35.7	18.66	21.07	4.97	16.15	- -	-34.97	-8.27	-20.73	-34.81	-14.74	-47.92
Profit Margin (%)	25.05	22.61	24.01	22.64	11.09	15.83	2.39	17.92	0.54	-31.24	-3.94	-16.51	-34.96	-15.2	-44.38
Net Income to Common Margin (%)	25.05	22.61	24.01	22.64	11.09	15.83	2.39	17.92	0.54	-31.24	-3.94	-16.51	-34.96	-15.2	-44.38
Effective Tax Rate (%)	36.92	39.23	36.91	36.57	40.55	24.87	52.49	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	17.91	18.65	21.58	24.34	11.61	16.62	2.29	15.37	0.45	-19.88	-2.88	-12.08	-31.55	-17.15	-68.45

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	99	9	234	295	92	145	152	140	210
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	14	13	14	16	13	7
LT Debt	- -	- -	- -	- -	- -	- -	99	9	234	281	79	131	136	128	203
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	1.08	0.08	2.9	-4.91	-1.44	-2.04	-1.84	-5.24	-14.88
Net Debt/EBITDA	-0.32	-0.46	-0.44	-0.22	-0.4	-0.38	-0.04	-0.88	1.74	-1.01	4.03	0.8	1.13	2.34	2.11
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	2.29	0.15	30.72	-2.23	-0.73	-1.17	-1.05	-1.59	-3.09
Net Debt/EBIT	-0.33	-0.48	-0.46	-0.24	-0.48	-0.45	-0.08	-1.67	18.46	-0.46	2.03	0.46	0.65	0.71	0.44
EBITDA to Interest Expense	- -	- -	- -	- -	796	600.67	15.25	35.97	6.72	-5.56	-9.68	-22.19	-28.52	-9.57	-1.34
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	796	600.67	15.25	35.97	6.72	-5.56	-9.68	-22.19	-28.52	-9.57	-1.34
EBIT to Interest Expense	- -	- -	- -	- -	671	511.33	7.2	18.97	0.63	-12.22	-19.2	-38.66	-49.86	-31.43	-6.46
Interest Expense	- -	- -	- -	- -	- -	- -	6	3	12	11	7	3	3	3	10
Common Equity/Total Assets	92.79	92.04	90.64	87.28	86.41	84.96	63.56	82.2	69.68	65.37	73.28	73.9	68.31	68.23	52.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	12.9	0.96	21.44	30.64	8.19	14.78	17.35	18.19	55.14
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	11.43	0.95	17.66	23.19	7.48	12.7	14.53	15.15	35.12
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	8.2	0.79	14.94	20.03	6	10.92	11.85	12.41	28.71
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	12.9	0.96	21.44	32.11	9.54	16.37	19.42	20.01	57.01
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	11.43	0.95	17.66	24.3	8.71	14.07	16.26	16.67	36.31
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	8.2	0.79	14.94	20.99	6.99	12.1	13.27	13.65	29.69
Net Debt to Equity	-9.29	-13.58	-14.28	-9.01	-9.68	-9.16	-0.43	-10.52	12.88	6.61	-26.6	-6.42	-11.95	-8.96	-8.07
Net Debt/Capital (%)	-10.25	-15.72	-16.66	-9.91	-10.72	-10.08	-0.43	-11.75	11.41	5.78	-32.07	-5.84	-11.65	-8.5	-6.94
EBITDA	165	189	237	288	159	180	92	115	81	-60	-64	-71	-83	-27	-14
EBITDA-CapEx	159	189	237	288	159	180	92	115	81	-60	-64	-71	-83	-27	-14
Operating Income (Loss)	158	180	228	274	134	153	43	61	8	-132	-127	-124	-145	-88	-68

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	10.08	7.57	5.77	2.31	2.11	2.2	0.69	1.77	1.16	1.48	1.66	0.84	0.9	0.62	1.12
Current Ratio	12.16	9.4	7.5	4	4.13	4.35	1.39	3.21	2.96	2.26	2.37	2	2.01	1.82	2.49
Quick Ratio	11.55	8.98	7.27	3.37	3.38	3.51	1.13	2.78	2.34	1.96	2.11	1.58	1.64	1.36	1.98
CFO/Avg Current Liab	4.23	3.57	3.18	2.62	1.88	2.36	0.73	0.73	0.76	0.46	0.11	-0.62	-0.76	-0.05	0.01
Common Equity/Total Assets	92.79	92.04	90.64	87.28	86.41	84.96	63.56	82.2	69.68	65.37	73.28	73.9	68.31	68.23	52.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	12.9	0.96	21.44	30.64	8.19	14.78	17.35	18.19	55.14
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	11.43	0.95	17.66	23.19	7.48	12.7	14.53	15.15	35.12
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	8.2	0.79	14.94	20.03	6	10.92	11.85	12.41	28.71
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	12.9	0.96	21.44	32.11	9.54	16.37	19.42	20.01	57.01
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	11.43	0.95	17.66	24.3	8.71	14.07	16.26	16.67	36.31
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	8.2	0.79	14.94	20.99	6.99	12.1	13.27	13.65	29.69
CFO/Total Liabilities	297.1	257.94	231.17	181.49	134.97	125.6	24.09	55.4	17.67	12.48	5.27	-33.97	-30.53	-2.66	0.53
CFO/CapEx	22.59	189.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	29.16	23.89	19.88	20.78	16.82	12.72	4.56	10.78	5.17	1.43	4.13	2.11	2.03	1.57	-0.44

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	8.2	8.96	7.92	8.83	8.62	8.34	8.01	7.84	7.29	6.32	8.66	7.03	6.98	7.11	6.97
Days Sales Outstanding	44.51	40.74	46.06	41.33	42.33	43.75	45.56	46.55	50.05	57.73	42.12	51.89	52.31	51.31	52.35
Inventory Turnover	11.37	6.53	9.61	7.56	6.02	4.96	4.25	4.63	6.12	6.15	8.9	11.41	11.22	10.19	8.53
Days Inventory Outstanding	32.11	55.86	37.97	48.31	60.67	73.56	85.81	78.79	59.65	59.33	41.01	31.98	32.53	35.82	42.77
Accounts Payable Turnover	5.42	6.32	5.17	6.21	6.72	8.08	8.13	7.05	6.68	6.68	7.17	7.08	8.72	8.87	8.06
Accounts Payable Turnover Days	67.33	57.79	70.55	58.75	54.28	45.17	44.92	51.74	54.63	54.61	50.94	51.54	41.85	41.15	45.3
Cash Conversion Cycle	9.29	38.81	13.48	30.89	48.71	72.13	86.45	73.6	55.07	62.45	32.19	32.34	42.99	45.99	49.82
Inventory to Cash Days	12.41	-15.13	8.1	-6.98	-18.34	-29.81	-40.26	-32.24	-9.61	-1.6	1.12	19.91	19.78	15.49	9.58
Inventories	8	12	5	24	25	38	42	34	31	29	15	20	22	28	31
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	8	12	5	24	25	38	42	34	31	29	15	20	22	28	31

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	1,959	1,963	2,165	2,861	2,342	2,114	1,767	2,638	2,042	847	2,208	1,178	1,721	1,252	575
- Cash & Cash Equivalents	53	86	104	65	64	68	102	111	93	164	257	57	132	102	150
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	99	9	234	295	92	145	152	140	210
Enterprise Value	1,612	1,622	1,793	2,674	2,197	1,955	1,715	2,467	2,138	924	1,962	1,208	1,732	1,290	635
Total Capital	567	636	729	719	662	748	867	975	1,322	1,213	1,060	1,031	935	841	578
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	11.43	0.95	17.66	24.3	8.71	14.07	16.26	16.67	36.31
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.06	- -	0.11	0.32	0.05	0.12	0.09	0.11	0.33
EV/Sales	4.01	3.27	2.92	3.44	3.04	2.64	2.35	3.32	2.51	1.45	2.84	1.78	2.3	1.54	0.77
EV/EBITDA	9.77	8.57	7.57	9.28	13.8	10.85	18.75	21.43	26.53	- -	- -	- -	- -	- -	- -
EV/EBIT	10.22	9	7.86	9.75	16.37	12.75	39.71	40.64	281.37	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	12.32	11.44	10.31	14.06	15.62	11.74	15.73	20.65	- -	13.14	90.21	- -	- -	- -	55.12
EV/Free Cash Flow to Firm	11.8	11.38	10.31	14.06	15.62	11.74	15.73	20.65	- -	13.14	90.21	- -	- -	- -	55.12
Diluted Market Cap	2,083	2,055	2,239	3,043	2,532	2,246	1,778	2,691	2,111	843	2,153	1,170	1,585	1,242	569
Diluted Enterprise Value	2,030	1,969	2,135	2,978	2,468	2,178	1,774	2,589	2,252	974	1,988	1,258	1,605	1,280	630
EV per Share	18.69	19.65	22.25	36.38	31.89	28.3	25.08	34.94	29.09	12.37	24.52	14.88	19.26	14.13	6.79
TTM Sales	402	496	613	778	723	740	729	744	851	639	691	678	753	838	824
TTM EBITDA	165	189	237	288	159	180	92	115	81	-60	-64	-71	-83	-27	-14
TTM Operating Income	158	180	228	274	134	153	43	61	8	-132	-127	-124	-145	-88	-68
TTM Cash Flow to Firm	131	142	174	190	141	167	109	119	- -	70	22	-104	-108	-6	12
TTM Free Cash Flow to Firm	137	143	174	190	141	167	109	119	- -	70	22	-104	-108	-6	12

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	15.24	14.42	12.88	16	18.02	13.51	16.74	23.22	25.22	13.88	115.74	-11	-14.29	-142.77	316.38
EV/EBIT	10.22	9	7.86	9.75	16.37	12.75	39.71	40.64	281.37	- -	- -	- -	- -	- -	- -
Enterprise Value	1,612	1,622	1,793	2,674	2,197	1,955	1,715	2,467	2,138	924	1,962	1,208	1,732	1,290	635
Low Price	14.11	17.51	23.07	20.02	31.34	28.82	15.15	23.28	22.07	9.24	19.5	13.92	13.82	12.87	3.76
EV/Sales	4.01	3.27	2.92	3.44	3.04	2.64	2.35	3.32	2.51	1.45	2.84	1.78	2.3	1.54	0.77
EV/EBITDA	9.77	8.57	7.57	9.28	13.8	10.85	18.75	21.43	26.53	- -	- -	- -	- -	- -	- -
Price/Earnings	20.25	17.93	14.78	16.73	30.22	18.28	101.43	19.46	443.88	- -	- -	- -	- -	- -	- -
Price/Earnings Average	17.59	16.65	14.95	13.08	31.7	22.42	80.98	16.9	556.29	-8.58	-85.7	-15.82	-6.16	-15.84	-1.95
Price/Earnings High	23.08	20.37	21.05	18.27	36.01	27.62	129.42	21.64	805.94	-18.03	-105.96	-20.47	-7.61	-20.85	-3.92
Price/Earnings Low	12.58	13.21	12.69	8.6	27.86	17.21	59.47	12.12	352.64	-3.44	-55.92	-10.02	-4.35	-9.16	-0.95
Price/Book Value	3.46	3.09	2.97	3.98	3.54	2.83	2.3	2.73	1.88	0.92	2.28	1.33	2.2	1.79	1.56
Price/Book Value Average	3	2.87	3.01	3.11	3.71	3.47	1.84	2.37	2.35	1.87	2.47	2.01	2.25	2.9	1.96
Price/Book Value High	3.94	3.51	4.23	4.34	4.21	4.27	2.93	3.04	3.4	3.94	3.05	2.61	2.78	3.82	3.93
Price/Book Value Low	2.15	2.27	2.55	2.05	3.26	2.66	1.35	1.7	1.49	0.75	1.61	1.28	1.59	1.68	0.96
Price/Tangible Book Value	3.96	3.49	3.29	8.3	8.01	6.5	-45.09	13.72	-157.06	-57.63	6.8	5.37	11.76	8.21	3.53
Price/Tangible Book Value Average	3.44	3.24	3.33	6.49	8.4	7.97	-36	11.92	-196.84	-117.1	7.37	8.14	12.05	13.33	4.43
Price/Tangible Book Value High	4.52	3.96	4.68	9.07	9.55	9.82	-57.53	15.26	-285.18	-245.95	9.11	10.53	14.88	17.55	8.87
Price/Tangible Book Value Low	2.46	2.57	2.82	4.27	7.39	6.12	-26.44	8.55	-124.78	-46.95	4.81	5.15	8.49	7.71	2.16
Price/Sales	5.07	4.05	3.55	3.79	3.35	2.89	2.42	3.49	2.4	1.32	3.12	1.72	2.1	1.48	0.69
Price/Sales Average	4.41	3.77	3.59	2.96	3.52	3.55	1.93	3.03	3.01	2.68	3.38	2.61	2.16	2.41	0.87
Price/Sales High	5.78	4.61	5.05	4.14	3.99	4.37	3.09	3.88	4.36	5.63	4.17	3.38	2.66	3.17	1.74
Price/Sales Low	3.15	2.99	3.05	1.95	3.09	2.72	1.42	2.17	1.91	1.08	2.2	1.65	1.52	1.39	0.42
Price/Cash Flow	15.59	14.18	12.51	15.5	17.25	12.88	16.62	22.38	24.39	13.88	115.74	-11	-14.29	-142.77	316.38
Price/Cash Flow Average	13.54	13.17	12.66	12.12	18.09	15.8	13.27	19.44	30.57	28.21	125.32	-16.66	-14.64	-231.71	397.33
Price/Cash Flow High	17.77	16.11	17.81	16.92	20.55	19.46	21.2	24.89	44.29	59.24	154.95	-21.57	-18.08	-305.12	795.85
Price/Cash Flow Low	9.68	10.45	10.74	7.97	15.9	12.13	9.74	13.94	19.38	11.31	81.77	-10.55	-10.32	-134.03	193.43
Price/Free Cash Flow Average	13.24	13.39	13.03	12.51	18.9	16.57	13.37	20.17	31.61	28.21	125.32	-16.66	-14.64	-231.71	397.33
Price/Free Cash Flow High	17.38	16.38	18.34	17.47	21.48	20.41	21.36	25.82	45.8	59.24	154.95	-21.57	-18.08	-305.12	795.85
Price/Free Cash Flow Low	9.47	10.62	11.05	8.23	16.62	12.72	9.81	14.46	20.04	11.31	81.77	-10.55	-10.32	-134.03	193.43
EV/Sales Average	4.1	3.5	3.4	2.79	3.31	3.41	1.93	2.95	3.17	2.9	3.22	2.76	2.37	2.47	0.95
EV/Sales High	5.42	4.32	4.86	3.93	3.77	4.22	3.09	3.81	4.52	5.87	4.04	3.54	2.92	3.24	1.83
EV/Sales Low	2.9	2.74	2.86	1.81	2.9	2.6	1.42	2.07	2.07	1.29	2.02	1.8	1.68	1.45	0.5
EV/EBITDA Average	9.99	9.17	8.81	7.54	15.03	14.01	15.38	19.03	33.49	-30.87	-34.83	-26.38	-21.55	-77.21	-55.49
EV/EBITDA High	13.21	11.32	12.58	10.61	17.13	17.35	24.61	24.62	47.74	-62.44	-43.68	-33.78	-26.56	-101.23	-106.85
EV/EBITDA Low	7.06	7.18	7.41	4.88	13.16	10.67	11.28	13.4	21.87	-13.69	-21.83	-17.16	-15.27	-45.26	-29.2
EV/EBIT Average	10.45	9.63	9.15	7.92	17.83	16.46	32.58	36.08	355.16	-14.03	-17.57	-15.14	-12.33	-23.52	-11.54
EV/EBIT High	13.82	11.88	13.07	11.15	20.32	20.38	52.12	46.68	506.27	-28.38	-22.03	-19.39	-15.19	-30.83	-22.22
EV/EBIT Low	7.38	7.54	7.7	5.13	15.61	12.54	23.9	25.4	231.9	-6.22	-11.01	-9.85	-8.73	-13.78	-6.07
Last Price	22.71	23.77	26.87	38.92	33.99	30.6	25.84	37.37	27.78	11.34	27.6	14.51	19.14	13.71	6.15
High Price	25.89	27	38.27	42.5	40.5	46.24	32.97	41.57	50.44	48.4	36.95	28.45	24.21	29.3	15.47
Enterprise Value Average	1,649	1,736	2,087	2,172	2,392	2,525	1,407	2,190	2,699	1,852	2,226	1,873	1,782	2,069	782
Enterprise Value High	2,180	2,143	2,980	3,059	2,726	3,127	2,251	2,833	3,848	3,747	2,791	2,398	2,196	2,713	1,507
Enterprise Value Low	1,164	1,359	1,755	1,407	2,095	1,923	1,033	1,542	1,762	821	1,395	1,218	1,262	1,213	412

Shares Outstanding	86	83	81	73	69	69	68	71	74	75	80	81	90	91	94
Diluted Weighted Avg Shares	92	86	83	78	74	73	69	72	76	74	78	81	83	91	93
Basic Weighted Avg Shares	90	85	81	76	71	70	68	69	74	74	78	81	83	91	93
Revenue per Share	4.48	5.86	7.58	10.28	10.14	10.58	10.67	10.72	11.58	8.59	8.85	8.42	9.1	9.25	8.9
EBITDA per Share	1.84	2.24	2.93	3.81	2.23	2.57	1.34	1.66	1.1	-0.81	-0.82	-0.88	-1	-0.3	-0.15
Operating Income per Share	1.76	2.13	2.82	3.62	1.88	2.19	0.63	0.87	0.1	-1.78	-1.62	-1.53	-1.75	-0.97	-0.73
Basic EPS, GAAP	1.12	1.33	1.82	2.33	1.12	1.67	0.25	1.92	0.06	-2.69	-0.35	-1.39	-3.18	-1.41	-3.95
Basic EPS from Cont Ops	1.12	1.33	1.82	2.33	1.12	1.67	0.25	1.92	0.06	-2.69	-0.35	-1.39	-3.18	-1.41	-3.95
Diluted EPS, GAAP	1.1	1.3	1.77	2.25	1.08	1.6	0.25	1.85	0.06	-2.69	-0.35	-1.39	-3.18	-1.41	-3.95
Diluted EPS from Cont Ops	1.1	1.3	1.77	2.25	1.08	1.6	0.25	1.85	0.06	-2.69	-0.35	-1.39	-3.18	-1.41	-3.95
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	1.46	1.68	2.15	2.51	1.97	2.38	1.55	1.67	1.14	0.82	0.24	-1.32	-1.34	-0.1	0.02
Free Cash Flow per Basic Share	1.39	1.67	2.15	2.51	1.97	2.38	1.55	1.67	1.14	0.82	0.24	-1.32	-1.34	-0.1	0.02
Cash & Equivalents per Share	4.02	4.12	4.62	2.54	2.1	2.3	2.2	2.56	1.86	2.92	4.24	1.42	1.57	1.12	1.6
Book Value per Share	6.57	7.7	9.04	9.78	9.61	10.83	11.23	13.68	14.81	12.29	12.1	10.91	8.71	7.68	3.94
Tangible Book Value per Share	5.73	6.82	8.17	4.69	4.24	4.71	-0.57	2.72	-0.18	-0.2	4.06	2.7	1.63	1.67	1.74

Myriad Genetics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)